EFFICACY AND SAFETY OF TAKEDA'S TETRAVALENT DENGUE VACCINE CANDIDATE (TAK-003) AFTER 4.5 YEARS OF FOLLOW-UP: RESULTS FROM PARTICIPANTS IN ASIA

Autor: Green, A., Biswal, S., Lloyd, E., Tricou, V., Folschweiller, N.
Zdroj: In International Journal of Infectious Diseases May 2023 130 Supplement 2:S11-S11
Databáze: ScienceDirect